Compazine and Injectafer drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Compazine (prochlorperazine maleate) and Injectafer (ferric carboxymaltose). Common drug interactions include constipation among females and decreased appetite among males.

The phase IV clinical study analyzes what interactions people have when they take Compazine and Injectafer. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Compazine?

Compazine has active ingredients of prochlorperazine maleate. It is often used in nausea and vomiting. eHealthMe is studying from 13,646 Compazine users. Check the latest studies of Compazine.

What is Injectafer?

Injectafer has active ingredients of ferric carboxymaltose. eHealthMe is studying from 3,270 Injectafer users. Check the latest studies of Injectafer.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 14, 2026

14 people who take Compazine and Injectafer together, and have interactions are studied.

Compazine and Injectafer drug interactions.

What are the common drug interactions of Compazine and Injectafer, by gender? *:

female:

Constipation
Fatigue (feeling of tiredness)
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Hypertension (high blood pressure)
Neuropathy peripheral (surface nerve damage)
Photosensitivity reaction
Malignant neoplasm progression (cancer tumour came back)
Abdominal pain upper
Blood pressure increased
Bone pain

male:

Decreased appetite
Fatigue (feeling of tiredness)
Malaise (a feeling of general discomfort or uneasiness)

What are the common drug interactions of Compazine and Injectafer, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Anaemia (lack of blood)
Hepatic adenoma (benign liver tumour)
Hypokalaemia (low potassium)
Post procedural haemorrhage (post procedural bleeding)

30-39:

n/a

40-49:

n/a

50-59:

Abdominal pain

60+:

Headache (pain in head)
Abdominal pain
Hypertension (high blood pressure)
Neuropathy peripheral (surface nerve damage)
Photosensitivity reaction
Malignant neoplasm progression (cancer tumour came back)
Abdominal pain upper
Blood pressure increased
Bone pain
Lung disorder (lung disease)

What are the existing conditions these people have? *

Ovarian Cancer (cancer of ovary): 9 people, 64.29%
Nausea (feeling of having an urge to vomit): 5 people, 35.71%
Pain In Extremity: 4 people, 28.57%
Malignant Peritoneal Neoplasm (cancer tumour of peritoneum): 2 people, 14.29%
Neck Pain: 2 people, 14.29%
Back Pain: 2 people, 14.29%
Hypocalcaemia (levels of calcium in blood serum are abnormally low): 1 person, 7.14%
Asthma: 1 person, 7.14%
Gastric Cancer (stomach cancer): 1 person, 7.14%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Compazine and Injectafer?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously